Furthermore, it is known that variants (SNPs) in the SLC26A9 anion transporter can influence disease severity in the CF lungs and gut (meconium ileus) and, therefore, act as gene modifiers. This evidence concerns the gene SLC26A9 and intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency.